The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: A randomised double-blind, placebo-controlled clinical trial

Beneficial Microbes

Volumn 8, Issue 5, 2017, Pages 697-703

  Lei, M ^a   Guo, C ^a   Wang, D ^a   Zhang, C ^a   Hua, L ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Bethune International Heping Hospital   (China)

Author keywords

Inflammation; Lactobacillus casei Shirota; Osteoarthritis; Pain; Probiotics

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; EVENING DOSAGE; HUMAN; KNEE OSTEOARTHRITIS; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI SHIROTA; MAJOR CLINICAL STUDY; MILK; MORNING DOSAGE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; CLINICAL TRIAL; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADMINISTRATION, ORAL; AGED; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PLACEBOS; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85031414941     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/bm2016.0207     Document Type: Article

References (36)

1. Ablij, H. and Meinders, A., 2002. C-reactive protein: history and revival. European Journal of Internal Medicine 13: 412
2. Ahmed, S., Anuntiyo, J., Malemud, C.J. and Haqqi, T.M., 2005. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evidence-Based Complementary and Alternative Medicine 2: 301-308
3. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M.R., Asemi, Z. and Esmaillzadeh, A., 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32: 315-320
4. Alipour, B., Homayouni-Rad, A., Vaghef-Mehrabany, E., Sharif, S.K., Vaghef-Mehrabany, L., Asghari-Jafarabadi, M., Nakhjavani, M.R. and Mohtadi-Nia, J., 2014. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. International Journal of Rheumatic Diseases 17: 519-527
5. Amdekar, S., Singh, V., Singh, R., Sharma, P., Keshav, P. and Kumar, A., 2011. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. Journal of Clinical Immunology 31: 147-154
6. Asemi, Z., Jazayeri, S., Najafi, M., Samimi, M., Mofid, V., Shidfar, F., Foroushani, A.R. and Shahaboddin, M.E., 2011. Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pakistan Journal of Biological Sciences 14: 476-482
7. Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S.S. and Esmaillzadeh, A., 2013. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Annals of Nutrition and Metabolism 63: 1-9
8. Baraf, H.S., Fuentealba, C., Greenwald, M., Brzezicki, J., O'Brien, K., Soffer, B., Polis, A., Bird, S., Kaur, A., Curtis, S.P. and EDGE Study Group, 2007. Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the etoricoxib versus diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. Journal of Rheumatology 34: 408-420
9. Bellamy, N., Buchanan, W.W., Goldsmith, C.H., Campbell, J. and Stitt, L.W., 1988. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Journal of Rheumatology 15: 1833-1840
10. Conrozier, T., Chappuis-Cellier, C., Richard, M., Mathieu, P., Richard, S. and Vignon, E., 1998. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Revue du Rhumatisme, English edition 65: 759-765
11. Coulson, S., Butt, H., Vecchio, P., Gramotnev, H. and Vitetta, L., 2013. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles. Inflammopharmacology 21: 79-90
12. Dalton, R.R., Hoffman, W.H., Passmore, G.G. and Martin, S.L., 2003. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Annals of Clinical and Laboratory Science 33: 435-442
13. Di Napoli, M. and Papa, F., 2003. Association between blood pressure and C-reactive protein levels in acute ischemic stroke. Hypertension 42: 1117-1123
14. Dong, H., Rowland, I., Thomas, L.V. and Yaqoob, P., 2013. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. European Journal of Nutrition 52: 1853-1863
15. Goldring, M.B., 2000. Osteoarthritis and cartilage: the role of cytokines. Current Rheumatology Reports 2: 459-465
16. Goldring, M.B. and Otero, M., 2011. Inflammation in osteoarthritis. Current Opinion in Rheumatology 23: 471-478
17. Lei, M., Hua, L.M. and Wang, D.W., 2016. The effect of probiotic treatment on elderly patients with distal radius fracture: a prospective double-blind, placebo-controlled randomised clinical trial. Beneficial Microbes 7: 631-637
18. Matsuzaki, T., Saito, M., Usuku, K., Nose, H., Izumo, S., Arimura, K. and Osame, M., 2005. A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. Journal of the Neurological Sciences 237: 75-81
19. Parvaneh, K., Jamaluddin, R., Karimi, G. and Erfani, R., 2014. Effect of probiotics supplementation on bone mineral content and bone mass density. Scientific World Journal: 595962
20. Pearle, A.D., Scanzello, C.R., George, S., Mandl, L.A., DiCarlo, E.F., Peterson, M., Sculco, T.P. and Crow, M.K., 2007. Elevated highsensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis and Cartilage 15: 516-523
21. Salminen, S., Ouwehand, A., Benno, Y. and Lee, Y.K., 1999. Probiotics: how should they be defined? Trends in Food Science and Technology 10: 107-110
22. Sanaie, S., Ebrahimi-Mameghani, M., Mahmoodpoor, A., Shadvar, K. and Golzari, S.E., 2013. Effect of a probiotic preparation (VSL#3) on cardiovascular risk parameters in critically-ill patients. Journal of Cardiovascular and Thoracic Research 5: 67-70
23. Smith, J.W., Martins, T.B., Gopez, E., Johnson, T., Hill, H.R. and Rosenberg, T.D., 2012. Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Therapeutic Advances in Musculoskeletal Disease 4: 315-325
24. So, J.S., Song, M.K., Kwon, H.K., Lee, C.G., Chae, C.S., Sahoo, A., Jash, A., Lee, S.H., Park, Z.Y. and Im, S.H., 2011. Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sciences 88: 358-366
25. Spector, T.D., Hart, D.J., Nandra, D., Doyle, D.V., Mackillop, N., Gallimore, J.R. and Pepys, M.B., 1997. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis and Rheumatism 40: 723-727
26. Stadlbauer, V., Mookerjee, R.P., Hodges, S., Wright, G.A., Davies, N.A. and Jalan, R., 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology 48: 945-951
27. Steves, C.J., Bird, S., Williams, F.M. and Spector, T.D., 2016. The microbiome and musculoskeletal conditions of aging: a review of evidence for impact and potential therapeutics. Journal of Bone and Mineral Research 31: 261-269
28. Sturmer, T., Brenner, H., Koenig, W. and Gunther, K.P., 2004. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Annals of the Rheumatic Diseases 63: 200-205
29. Suri, P., Morgenroth, D.C. and Hunter, D.J., 2012. Epidemiology of osteoarthritis and associated comorbidities. PM&R 4: S10-S19
30. Takahashi, M., Naito, K., Abe, M., Sawada, T. and Nagano, A., 2004. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Research and Therapy 6: R208-212
31. Towheed, T.E., Judd, M.J., Hochberg, M.C. and Wells, G., 2003. Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews: CD004257
32. Vitetta, L., Coulson, S., Linnane, A.W. and Butt, H., 2013. The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics. Pathogens 2: 606-626
33. Wolfe, F., 1997. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. Journal of Rheumatology 24: 1486-1488
34. Wu, C.W., Morrell, M.R., Heinze, E., Concoff, A.L., Wollaston, S.J., Arnold, E.L., Singh, R., Charles, C., Skovrun, M.L., FitzGerald, J.D., Moreland, L.W. and Kalunian, K.C., 2005. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Seminars in Arthritis and Rheumatism 35: 197-201
35. Zamani, B., Golkar, H.R., Farshbaf, S., Emadi-Baygi, M., Tajabadi-Ebrahimi, M., Jafari, P., Akhavan, R., Taghizadeh, M., Memarzadeh, M.R. and Asemi, Z., 2016. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. International Journal of Rheumatic Diseases 19: 869-879
36. Zarrati, M., Salehi, E., Nourijelyani, K., Mofid, V., Zadeh, M.J., Najafi, F., Ghaflati, Z., Bidad, K., Chamari, M., Karimi, M. and Shidfar, F., 2014. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. Journal of the American College of Nutrition 33: 417-425